Research & Innovation
Publications
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al
PMU Authors
Tobias Kiesslich, Christian Mayr, Dino Bekric, Daniel Neureiter
All Authors
Tobias Kiesslich, Christian Mayr, Dino Bekric, Daniel Neureiter
Journal association
TRANSLATIONAL ONCOLOGY